Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation

Transplantation Proceedings

Volumn 44, Issue 5, 2012, Pages 1231-1235

  Thiyagarajan, U Mathuram ^a   Bagul, A ^a   Frost, J ^a   Horsburgh, T ^a   Nicholson, M L ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DONOR SPECIFIC ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ENGLAND; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861893412     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.10.054     Document Type: Article

References (19)

1. Patel R, Terasaki P: Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735, 1969
2. Ishida H, Tanabe K, Furusawa M, et al: Evaluation of flow cytometric panel reactive antibody in renal transplant recipients examination of 238 cases of renal transplantation. Transpl Int 18:163, 2005
3. Bielmann D, Honger G, Lutz D, et al: Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 7:626, 2007
4. Patel AM, Pancoska C, Mulgaonkar S, et al: Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 7:2371, 2007
5. Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al: Clinical relevance of preformed HLA donorspecific antibodies in kidney transplantation. Am J Transplant 8:324, 2008
6. Billen EVA, Christiaans MHL, van den Berg-Loonen EM: Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants. Tissue Antigens 74:205, 2009
7. Phelan D, Thalachallour M, Ramachandran S, et al: Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay. Human Immunol 70:584, 2009
8. Tuncera M, Gurkanb A, Erdoganb O, et al: Lack of impact of human leukocyte antigen matching in living donor kidney transplantation: experience at Akdeniz University. Transplant Proc 37:2969, 2005
9. Fuggle SV, Martin S: Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation 86:384, 2008
10. Cecka JM, Zhang Q, Reed EF: Preformed cytotoxic antibodies in potential allograft recipients: recent data. Human Immunol 66:343, 2005
11. Gibney EM, Cagle LR, Freed B, et al: Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant 21:2625, 2006
12. Susal C, Dohler B, Opelz G: Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: A Collaborative Transplant Study report. Human Immunol 70:569, 2009
13. Tuncera M, Gurkanb A, Erdoganb O, et al: Lack of impact of human leukocyte antigen matching in living donor kidney transplantation: experience at Akdeniz University. Transplant Proc 37:2969, 2005
14. Glassock RJ, Feldman D, Reynolds ES, et al: Human renal isografts: a clinical and pathologic analysis. Medicine 47:411, 1968
15. Aubert V, Venetz J-P, Pantaleo G, et al: Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Human Immunol 70:580, 2009
16. Andresdottir MB, Hoitsma AJ, Assmann KJ, et al: The impact of recurrent glomerulonephritis on graft survival in recipients of human histocompatibility leucocyte antigen-identical living related donor grafts. Transplantation 68:623, 1999
17. Berger J, Yaneva H, Nabarra B, et al: Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 7:232, 1975
18. Ponticelli C, Traversi L, Feliciani A, et al: Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 60:1948, 2001
19. McDonald SP, Russ GR: Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation 82:759, 2006